CARMENA Trial Randomized Patients | Either Tyrosine-Kinase Inhibitor, or Surgery & Sunitnib

Aly-Khan A. Lalani, MD, FRCPC Juravinski Cancer Centre, explains CARMENA Trial Randomized Patients | Either Tyrosine-Kinase Inhibitor, or Surgery & Sunitnib at Annual Meeting 2018